Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Schett

Showing results (61-70 of 1,049) with videos related to

Pageof 105
Sort By:
Nature Reviews. Rheumatology|December 1, 2020
Key opinion leaders - a critical perspectiveJose U Scher, Georg Schett
Nature Reviews. Rheumatology|September 30, 2018
Effects of the IL-23-IL-17 pathway on bone in spondyloarthritisEllen M Gravallese, Georg Schett
The New England Journal of Medicine|December 14, 2011
The pathogenesis of rheumatoid arthritisIain B McInnes, Georg Schett
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 30, 2009
Osteoclasts and ArthritisGeorg Schett, Steven L Teitelbaum
Annals of the Rheumatic Diseases|May 5, 2022
Sequential interleukin-17/interleukin-23 inhibition in treatment-refractory psoriatic arthritisDavid Simon, Filippo Fagni, Georg Schett
Annals of the Rheumatic Diseases|October 19, 2014
The impact of rheumatoid factor and ACPA on bone erosion in rheumatoid arthritisCarolin Hecht, Georg Schett, Stephanie Finzel
The New England Journal of Medicine|May 1, 2024
CAR T-Cell Therapy in Autoimmune Disease. ReplyFabian Müller, Andreas Mackensen, Georg Schett
The Lancet. Neurology|May 17, 2024
B cell-targeting chimeric antigen receptor T cells as an emerging therapy in neuroimmunological diseasesAiden Haghikia, Georg Schett, Dimitrios Mougiakakos
EULAR Rheumatology Open|June 29, 2026
Editorial-Immune reset in sight: CAR-T cell therapy in autoimmune diseaseMelanie Hagen, Georg Schett, Andreas Wirsching
The New England Journal of Medicine|November 27, 2009
Denosumab, osteoporosis, and prevention of fracturesStefan Kiechl, Johann Willeit, Georg Schett
Pageof 105

Showing results (61-70 of 1,049) with videos related to

Sort By:
Pageof 105
Nature Reviews. Rheumatology|December 1, 2020
Key opinion leaders - a critical perspectiveJose U Scher, Georg Schett
Nature Reviews. Rheumatology|September 30, 2018
Effects of the IL-23-IL-17 pathway on bone in spondyloarthritisEllen M Gravallese, Georg Schett
The New England Journal of Medicine|December 14, 2011
The pathogenesis of rheumatoid arthritisIain B McInnes, Georg Schett
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 30, 2009
Osteoclasts and ArthritisGeorg Schett, Steven L Teitelbaum
Annals of the Rheumatic Diseases|May 5, 2022
Sequential interleukin-17/interleukin-23 inhibition in treatment-refractory psoriatic arthritisDavid Simon, Filippo Fagni, Georg Schett
Annals of the Rheumatic Diseases|October 19, 2014
The impact of rheumatoid factor and ACPA on bone erosion in rheumatoid arthritisCarolin Hecht, Georg Schett, Stephanie Finzel
The New England Journal of Medicine|May 1, 2024
CAR T-Cell Therapy in Autoimmune Disease. ReplyFabian Müller, Andreas Mackensen, Georg Schett
The Lancet. Neurology|May 17, 2024
B cell-targeting chimeric antigen receptor T cells as an emerging therapy in neuroimmunological diseasesAiden Haghikia, Georg Schett, Dimitrios Mougiakakos
EULAR Rheumatology Open|June 29, 2026
Editorial-Immune reset in sight: CAR-T cell therapy in autoimmune diseaseMelanie Hagen, Georg Schett, Andreas Wirsching
The New England Journal of Medicine|November 27, 2009
Denosumab, osteoporosis, and prevention of fracturesStefan Kiechl, Johann Willeit, Georg Schett
Pageof 105